Navigation Links
Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models"
Date:8/21/2014

Chester, NJ (PRWEB) August 21, 2014

Pursuit Solutions (http://www.pursuit-solutions.com), a provider of personal selling optimization technology and services for Life Sciences sales and marketing organizations, announced the publication of “Grading Pharma’s Use of New Commercial Sales Models” by Peter Robinson, co-founder and head of Measurement & Analytics.

The article examines some innovative models used to improve sales and marketing yield that are being tested in the pharmaceutical market. Robinson grades the industry on its progress against each model and proposes solutions to close remaining gaps.

To view the full article, visit http://www.pm360online.com/grading-pharmas-use-of-new-commercial-sales-models/.

About Pursuit Solutions

Pursuit Solutions provides sales and marketing optimization solutions for Life Sciences. Its flagship product, ClearSky, provides the pharmaceutical Field Force with an intuitive and powerful Closed-Loop Marketing (CLM) and Sales Force Automation (SFA) solution, that in concert with the client’s Multi-Channel Marketing (MCM) system enables the user to be aware of marketing touch-points, receive data-driven Interactive Visual Aid (IVA) and other tactic recommendations, and cater presentations to their customers’ interests. ClearView, the company’s business intelligence platform, is designed specifically for the pharmaceutical industry, combining Field Force, Marketing and Managed Markets metrics and insights in one place.

Pursuit's Data Management, Campaign Operations, and Strategy & Analytics capabilities enable its clients to take advantage of alignment across sales and marketing channels, so that customers have a valuable and consistent experience.

Pursuit Solutions is headquartered in Chester, NJ, with offices in Boston, MA, and in the southern San Francisco and Orange County, CA areas. For more information, visit http://www.pursuit-solutions.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12108877.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pursuit's Elissa Guerra and Eunjoo Pluenneke to Present on Mobile Strategy at Digital Pharma West Conference
2. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
3. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
4. PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
5. Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagenes Scientific Advisory Board
6. American Botanical Council Publishes a History of Adulteration
7. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
8. Nonprofit Consortium Publishes Review of Skullcap Adulteration
9. Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science
10. Seaside publishes research supporting disease-modifying potential of STX209 for fragile X syndrome
11. R&D Systems Publishes 100,000 Product Detail Web Pages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a ... its financial results for the fourth quarter and fiscal year ... Total sales in the fourth quarter ... by 13.6% in USD terms to $77.6 million from $68.3 ... Gross profit increased by 13.3% to $46.8 million from $41.3 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):